As AI continues to transform the health care industry, AI developers must navigate a complex landscape from design and development to premarket application entry and reimbursement. This webinar explores the legal, regulatory and policy considerations developers should take into account when looking at FDA premarket strategies and commercializing artificial intelligence (AI) medical technologies.
We provide health tech executives, investors, and innovators developing AI-powered health care solutions key takeaways to help plan in advance at key phases of the product lifecycle to best position a commercialization strategy.
Key Topics
- Strategic planning for entry to market
- FDA regulatory framework for AI in medical technology
- Reimbursement considerations
- Accessing health care data for training, testing, and using AI
About the Series
AI Legal Insights: Shaping Tomorrow provides a cross-disciplinary look at the myriad of legal facets that AI is impacting now and anticipated to shape tomorrow. View our Webinar Series page to see the full list of programs.